Zura Bio (ZURA) Non Operating Investment Income (2022)
Zura Bio's (ZURA) quarterly Non Operating Investment Income came in at $1.2 million in Q4 2022, up 73.51% quarter-over-quarter from $686544.0 in Q3 2022.
Zura Bio (ZURA) Non Operating Investment Income (2022) Analysis & Trends
Zura Bio's Non Operating Investment Income history runs 1 years deep, the most recent figure standing at $1.2 million for Q4 2022.
- On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to $1.2 million in Q4 2022; TTM through Dec 2022 was $2.1 million, a N/A change from a year earlier, with the FY2022 full-year figure at $2.1 million, up 10791.67% from the prior year.
- Non Operating Investment Income grew to $1.2 million in Q4 2022 per ZURA's latest filing, from $686544.0 in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $1.2 million in Q4 2022 and bottomed at $16299.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Zura Bio | 609.93 Mn | 609.93 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.19 Mn |
| Dec 31, 2022 | 1.19 Mn |
| Sep 30, 2022 | 686,544.00 |
| Sep 30, 2022 | 686,544.00 |
| Jun 30, 2022 | 181,213.00 |
| Jun 30, 2022 | 181,213.00 |
| Mar 31, 2022 | 16,299.00 |
| Mar 31, 2022 | 16,299.00 |